Go Pro

Akari Therapeutics (AKTX) Earnings Date, Estimates & Call Transcripts

Akari Therapeutics logo
$10.32 -0.39 (-3.60%)
As of 11:15 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Akari Therapeutics Earnings Summary

Akari Therapeutics released Q4 2025 earnings on March 30, 2026, reporting an EPS of -$2.68, which missed analysts' consensus estimates of -$0.03 by $2.65. Akari Therapeutics currently has a trailing EPS of $0.00

Latest Q4
Earnings Date
Mar. 30Estimated
Consensus EPS
(Mar. 30)
-$0.03
Actual EPS
(Mar. 30)
-$2.68 Missed By -$2.65
Get Akari Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Akari Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Akari Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/30/2026Q4 2025-$0.03-$2.68 -$2.65-$2.6650--

Earnings data for NASDAQ:AKTX is sourced from Fiscal.ai, with the most recent quarter reported on 3/30/2026. New results are added as companies report their earnings.
From Our Partners